Skip to main content
SpringerLink
Log in

Immunological approaches to cancer treatment

  • Published:
The Japanese journal of surgery Aims and scope Submit manuscript

Abstract

Immunological approaches to cancer treatment are reviewed to consider the role of specifically sensitized effector cells as well as non-specific mechanisms. The induction of immunity by specific mechanisms is exemplified by the response to carcinogen induced animal tumours but this is contrasted with the lack of this type of response with naturally occurring animal tumours. These experimental findings are reviewed in relation to the clinical approaches to active immunotherapy.

Regional immunotherapy, where bacterial adjuvants are administered so as to localize in tumour deposits is generally more effective than systemic immunotherapy. This is discussed in relation to the animal studies and these approaches are reviewed, particularly in connection with the treatment of human lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baldwin, R. W. and Byers, V. S.: Immunoregulation by bacterial organisms and their role in the immunotherapy of cancer,Seminars in Immunopathology, 1 (in press), 1978.

  2. Baldwin, R. W. and Pimm, M. V.: Influence of BCG infection on growth of 3-methylcholan-threne-induced rat sarcomas,Europe J. Clin. Biol. Res. 16: 875–881, 1971.

    CAS  Google Scholar 

  3. Baldwin, R. W. and Pimm, M. V.: BCG immunotherapy of local subcutaneous growths and postsurgical pulmonary metastases of a transplanted rat epithelioma of spontaneous origin,Int. J. Cancer 12: 420–427, 1973.

    PubMed  CAS  Google Scholar 

  4. Baldwin, R. W. and Pimm, M. V.: BCG in tunour immunotherapy,Adv. Cancer Res. 28: 91–147, 1978.

    PubMed  CAS  Google Scholar 

  5. Baldwin, R. W. and Robins, R. A.: Induction of tumor-immune responses and their interactions within the developing tumor,Contemp. Topics Mol. Immunol. 6: 177–207, 1977.

    CAS  Google Scholar 

  6. Baldwin, R. W., Embleton, M. J. and Pimm, M. V.: Host responses to spontaneous rat tumours. In Antiviral Mechanisms in the Control of Neoplasia. Plenum Press, New York (in press), 1978.

    Google Scholar 

  7. Broder, S., Muuel, L. and Waldmann, T. A.: Suppressor cells in neoplastic disease,J. Natl. Cancer Inst. 61: 5–11, 1978.

    PubMed  CAS  Google Scholar 

  8. Cerottini, J. C. and Brunner, K. T.: Cell mediated cytotoxicity, allograft rejection and tumor immunity,Adv. Immunol., 18: 67–132, 1974.

    Article  PubMed  CAS  Google Scholar 

  9. Goodnight, J. E. and Morton, D. L.: Immunotherapy for malignant disease,Ann. Rev. Med. 29: 231–283, 1978.

    Article  PubMed  Google Scholar 

  10. Haller, O., Hansson, M., Kiessling, R. and Wigzell, H.: Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo,Nature 270: 609–611, 1977.

    Article  PubMed  CAS  Google Scholar 

  11. Hellström, K. E., Hellström, I. and Nepom, J. T.: Specific blocking factors—are they important?Biochim. Biophys. Acta (CR) 473: 121–148, 1977.

    Google Scholar 

  12. Herberman, R. B.: Cell-mediated immunity to tumor cells,Adv. Cancer Res. 19: 207–263, 1974.

    PubMed  CAS  Google Scholar 

  13. Herberman, R. B. and Holden, H. T.: Natural cell-mediated immunity,Adv. Cancer res. 27: 305–377, 1978.

    PubMed  CAS  Google Scholar 

  14. Iles, P. B., Shore, D. F., Langman, M. J. S. and Baldwin, R. W.: Intrapleural BCG in operable lung cancer. In Recent Results in Cancer Research, Springer-Verlag (in press), 1978.

  15. James, K.: The influence of tumour cell-products on macrophage functionin vitro andin vivo: a review. In K. James, B. McBride and A. Stuart (Eds.), The Macrophage and Cancer. Edinburgh, pp. 225–246, 1977.

  16. Klein, E. and Sjögren, H. O.: Humoral and cellular factors in homograft and isograft immunity against sarcoma cells,Cancer Res. 20: 452–461, 1960.

    PubMed  CAS  Google Scholar 

  17. Ludwig Lang Cancer Study Group: Search for the possible role of ‘immunotherapy’ in operable bronchial non-small cell carcinoma (Stage I and II): a Phase I study withCorynebacterium parvum intrapleurally,Cancer Immunol. Immunother 4: 69–75, 1978.

    Google Scholar 

  18. McIllmurray, M. B., Embleton, M. J., Reeves, W. G., Langman, M. J. S. and Deane, M.: Controlled trial of active immunotherapy in management of stage IIB malignant melanoma,Br. Med. I. 1: 540–542, 1977.

    Article  CAS  Google Scholar 

  19. McKneally, M. F., Maver, C. and Kausel H. W.: Regional immunotherapy of lung cancer with intrapleural BCG,Lancet 1: 377–379, 1976.

    Article  PubMed  CAS  Google Scholar 

  20. McKneally, M. F., Maver, C. and Kausel, H. W.: Intrapleural BCG immunostimulation in lung cancer,Lancet 1: 1003, 1977.

    Article  PubMed  CAS  Google Scholar 

  21. Milas, L. and Scott, M. T.: Antitumor activity ofCorynebacterium parvum, Adv. Cancer Res. 26: 257–306, 1978.

    Article  PubMed  CAS  Google Scholar 

  22. Morton, D. L., Eilber, F. R., Malmgren, R. A. and Wood, W. C.: Immunological factors which influence response to immunotherapy in malignant melanoma,Surgery 68: 158–164, 1970.

    PubMed  CAS  Google Scholar 

  23. Morton, D. L., Holmes, E. C., Eilber, F. R., Sparks, F. R. and Ramming, K. P.: Adjuvant immunotherapy of malignant melanoma: prelimniary results of a randomized trial in patients with lymph node metastases. In W. D. Terry and D. Windhorst (Eds.), Immunotherapy of Cancer: Present Status of Trials in Man. Raven Press, New York, pp. 57–72, 1978.

    Google Scholar 

  24. Perlmann, P., Perlmann, H., Wahlin, B. and Hammarström, S.: Quantitation, fractionation and surface marker analysis of IgG- and IgM-dependent cytolytic lyphocytes (K cells) in human blood. In P. A. Miescher (Ed.), Immunopathology VIIth International Symposium. Schwabe, Basel, pp. 321–334, 1977.

    Google Scholar 

  25. Roscoe, P., Pearce, S., Ludgate, S. and Horne, N. W.: A controlled trial of BCG immunotherapy in bronchogenic carcinoma treated by surgical resection,Cancer Immunol. Immunother. 3: 115–118, 1977.

    Article  Google Scholar 

  26. Treves, A. J.: In vitro induction of cell-mediated immunity against tumor cells by antigen-fed macrophages,Immunol. Rev. 40: 205–226, 1978.

    Article  PubMed  CAS  Google Scholar 

  27. Willmott, N., Pimm, M. V. and Baldwin, R. W.: Comparison ofBCG andC. parvum preparztions for adjuvant contact therapy of a rat sarcoma,Develop. Biol., 1978.

  28. Yamamura, Y.: Immunotherapy of lung cancer with oil-attached cell wall skeleton of BCG. In W. D. Terry and D. Windhorst (Eds.), Immunotherapy of Cancer: Present Status of Trials in Man. Raven Press, New York. pp. 173–179, 1978.

    Google Scholar 

  29. Zbar, B., Bernstein, I. D. and Rapp, H. J.: Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin,J. Natl. Cancer Inst. 46: 831–839, 1971.

    PubMed  CAS  Google Scholar 

  30. Zbar, B., Bernstein, I. D., Bartlett, G. L., Hanna, M. G. and Rapp, H. J.: Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of livingMycobacterium bovis, J. Natl. Cancer Inst. 49: 119–130, 1972.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Research Campaign Laboratories, University of Nottingham, University Park, NG7 2RD, Nottingham

    R. W. Baldwin

Authors
  1. R. W. Baldwin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baldwin, R.W. Immunological approaches to cancer treatment. The Japanese Journal of Surgery 10, 7–14 (1980). https://doi.org/10.1007/BF02468641

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02468641

Key Words

Search

Navigation